Home Cart 0 Sign in  

[ CAS No. 593-85-1 ]

{[proInfo.proName]} ,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
HazMat Fee +

There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.

Type HazMat fee for 500 gram (Estimated)
Excepted Quantity USD 0.00
Limited Quantity USD 15-60
Inaccessible (Haz class 6.1), Domestic USD 80+
Inaccessible (Haz class 6.1), International USD 150+
Accessible (Haz class 3, 4, 5 or 8), Domestic USD 100+
Accessible (Haz class 3, 4, 5 or 8), International USD 200+
Chemical Structure| 593-85-1
Chemical Structure| 593-85-1
Structure of 593-85-1 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Bulk Inquiry Add To Cart

Quality Control of [ 593-85-1 ]

Related Doc. of [ 593-85-1 ]

Alternatived Products of [ 593-85-1 ]

Product Details of [ 593-85-1 ]

CAS No. :593-85-1 MDL No. :MFCD00013029
Formula : C3H12N6O3 Boiling Point : -
Linear Structure Formula :- InChI Key :STIAPHVBRDNOAJ-UHFFFAOYSA-N
M.W :180.17 Pubchem ID :11650
Synonyms :

Calculated chemistry of [ 593-85-1 ]

Physicochemical Properties

Num. heavy atoms : 12
Num. arom. heavy atoms : 0
Fraction Csp3 : 0.0
Num. rotatable bonds : 0
Num. H-bond acceptors : 5.0
Num. H-bond donors : 8.0
Molar Refractivity : 42.51
TPSA : 209.31 Ų

Pharmacokinetics

GI absorption : Low
BBB permeant : No
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -9.4 cm/s

Lipophilicity

Log Po/w (iLOGP) : -1.05
Log Po/w (XLOGP3) : -2.82
Log Po/w (WLOGP) : -2.1
Log Po/w (MLOGP) : -3.07
Log Po/w (SILICOS-IT) : -0.79
Consensus Log Po/w : -1.97

Druglikeness

Lipinski : 1.0
Ghose : None
Veber : 1.0
Egan : 1.0
Muegge : 5.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : 0.82
Solubility : 1190.0 mg/ml ; 6.6 mol/l
Class : Highly soluble
Log S (Ali) : -1.02
Solubility : 17.2 mg/ml ; 0.0954 mol/l
Class : Very soluble
Log S (SILICOS-IT) : 0.92
Solubility : 1510.0 mg/ml ; 8.36 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 2.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 2.11

Safety of [ 593-85-1 ]

Signal Word:Danger Class:N/A
Precautionary Statements:P264-P270-P273-P280-P301+P312+P330-P305+P351+P338+P310-P501 UN#:N/A
Hazard Statements:H302-H318-H402 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 593-85-1 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 593-85-1 ]
  • Downstream synthetic route of [ 593-85-1 ]

[ 593-85-1 ] Synthesis Path-Upstream   1~21

  • 1
  • [ 593-85-1 ]
  • [ 94-02-0 ]
  • [ 56741-94-7 ]
YieldReaction ConditionsOperation in experiment
70% at 80℃; Inert atmosphere General procedure: To a suspension of guanidine carbonate (1.5-5 eq) in ethanol (2 mL/mmol) was added γ-aryl-β-ketoester (1.43-26.6 mmol), and the reaction mixture heated at 80 °C for 15-64 h. Followingreaction completion by TLC, the mixture was cooled to ambient temperature, filtered and thesolid triturated with water (5-20 mL) and acetone (5-20 mL) to give the title compound.
Reference: [1] Tetrahedron, 2015, vol. 71, # 39, p. 7339 - 7343
[2] Journal of the American Chemical Society, 1998, vol. 120, # 27, p. 6761 - 6769
[3] Justus Liebigs Annalen der Chemie, 1891, vol. 262, p. 365
[4] Journal fuer Praktische Chemie (Leipzig), 1893, vol. <2> 47, p. 203
  • 2
  • [ 36437-19-1 ]
  • [ 593-85-1 ]
  • [ 5428-89-7 ]
Reference: [1] Yakugaku Zasshi, 1951, vol. 71, p. 39
[2] Journal of the American Chemical Society, 1942, vol. 64, p. 567,569,570
  • 3
  • [ 41850-84-4 ]
  • [ 593-85-1 ]
  • [ 1193-74-4 ]
Reference: [1] Yakugaku Zasshi, 1951, vol. 71, p. 1345,1347[2] Chem.Abstr., 1952, p. 8034
  • 4
  • [ 22428-91-7 ]
  • [ 593-85-1 ]
  • [ 1193-74-4 ]
Reference: [1] Chemische Berichte, 1930, vol. 63, p. 2601,2607
  • 5
  • [ 64-17-5 ]
  • [ 50421-80-2 ]
  • [ 593-85-1 ]
  • [ 1193-74-4 ]
Reference: [1] Chemische Berichte, 1950, vol. 63, p. 2604
  • 6
  • [ 593-85-1 ]
  • [ 4949-44-4 ]
  • [ 5734-66-7 ]
Reference: [1] Journal of the American Chemical Society, 1936, vol. 58, p. 287
[2] Journal of the Chemical Society, 1936, p. 157
  • 7
  • [ 609-32-5 ]
  • [ 593-85-1 ]
  • [ 3073-77-6 ]
Reference: [1] Kagaku Kenkyusho Hokoku, 1951, vol. 27, p. 401; vgl. E I 24 231[2] Chem.Abstr., 1953, p. 2181
  • 8
  • [ 593-85-1 ]
  • [ 118-92-3 ]
  • [ 20198-19-0 ]
Reference: [1] Chemische Berichte, 1905, vol. 38, p. 1212[2] Chemische Berichte, 1910, vol. 43, p. 1021
  • 9
  • [ 593-85-1 ]
  • [ 394-47-8 ]
  • [ 1899-48-5 ]
Reference: [1] ACS Medicinal Chemistry Letters, 2016, vol. 7, # 5, p. 502 - 507
  • 10
  • [ 593-85-1 ]
  • [ 1885-29-6 ]
  • [ 1899-48-5 ]
Reference: [1] ACS Medicinal Chemistry Letters, 2016, vol. 7, # 5, p. 502 - 507
  • 11
  • [ 593-85-1 ]
  • [ 141-97-9 ]
  • [ 3977-29-5 ]
Reference: [1] Journal of Heterocyclic Chemistry, 2004, vol. 41, # 3, p. 343 - 348
  • 12
  • [ 7520-69-6 ]
  • [ 124-41-4 ]
  • [ 593-85-1 ]
  • [ 738-70-5 ]
Reference: [1] Journal of Organic Chemistry, 1992, vol. 57, # 13, p. 3531 - 3535
  • 13
  • [ 593-85-1 ]
  • [ 55314-16-4 ]
  • [ 66521-66-2 ]
YieldReaction ConditionsOperation in experiment
66% With sodium hydroxide In butan-1-ol at 120℃; for 2 h; NaOH (0.78 g, 19.5 mmol) was added to a mixture of 3-(dimethylamino)-l-(pyridin-3- yl)prop-2-en-l-one (3.52 g, 20.0 mmol) and guanidine carbonate (1.80 g) in n-butanol (20 mL). The mixture was heated at 1200C for 2 h. After cooling, the precipitates formed was collected by filtration and dried under vacuum to afford the desired product (2.3g, 66percent). LCMS: (M+H)+= 173.2.
Reference: [1] Patent: WO2010/96395, 2010, A1, . Location in patent: Page/Page column 36
[2] Patent: WO2008/130944, 2008, A1, . Location in patent: Page/Page column 15-16
  • 14
  • [ 59938-06-6 ]
  • [ 593-85-1 ]
  • [ 16075-42-6 ]
Reference: [1] Chemistry of Heterocyclic Compounds (New York, NY, United States), 1991, vol. 27, # 4, p. 398 - 406[2] Khimiya Geterotsiklicheskikh Soedinenii, 1991, # 4, p. 502 - 511
  • 15
  • [ 593-85-1 ]
  • [ 50-01-1 ]
Reference: [1] Zeitschrift fur Anorganische und Allgemeine Chemie, 2018, vol. 644, # 5, p. 280 - 287
  • 16
  • [ 593-85-1 ]
  • [ 105942-08-3 ]
  • [ 137553-43-6 ]
Reference: [1] Journal of Heterocyclic Chemistry, 1991, vol. 28, # 5, p. 1357 - 1364
  • 17
  • [ 593-85-1 ]
  • [ 93777-26-5 ]
  • [ 190273-89-3 ]
YieldReaction ConditionsOperation in experiment
68% at 140℃; Step 1 : 5-Bromo-2-fluorobenzaldehyde (4.0 g, 19.7 mmol, 1.0 equiv) and guanidine carbonate (2.68 g, 29.7 mmol, 1.51 equiv) were dissolved in DMA (20 mL) and heated to 140°C & stirred for overnight. After completion of starting material, reaction mixture was poured onto ice cold water. The solid was filtered, washed with diethyl ether and dried to get 6-bromoquinazolin-2- amine (3.0 g, 68percent) as off white solid. LCMS (ES) m/z = 234.0, 236.0 [M+H]+. H NMR (400 MHz, DMSO-d6) δ 6.96 (s, 2H), 7.34 (d, J = 8.8 Hz, 1 H), 7.74 - 7.77 (m, 1 H), 8.03 (d, J = 2.0 Hz, 1 H), 9.07 (s, 1 H).
60% at 140℃; for 5 h; 2-Fluoro-5-bromobenzaldehyde (10 g, 49.2 mmol) and bisguanidinium carbonate (13.3 g, 74 mmol) were dissolved in N,N-dimethylacetamide (50 mL). The resulting mixture was heated to reflux and stirred for 5 h. After cooling to room temperature, 120 mL water was added and the reaction mixture was allowed to stir for another 2 h at room temperature. The product was collected by filtration and dried under vacuum to afford 6-bromo-2-quinazolinamine (2) (5.0 g, 60percent).
4 g at 160℃; for 0.5 h; To a solution of 5-bromo-2-fluoro-benzaldehyde (20.0 g, 98.5 mmol) in DMA (700 mL) was added guanidine-carbonic acid (26.6 g, 147.7 mmol). The mixture was stirred at 160°C for 0.5 h, cooled to rt and concentrated. The residue was diluted with H20 (300 mL) and extracted with ethyl acetate (200 mL χ 3). The combined organic layers were washed with brine (100 mL x 3), dried over Na2S04, filtered and concentrated under reduced pressure to give a residue. The residue was washed with DCM (300 mL) to get compound 1A-2 (4.0 g).
Reference: [1] Patent: WO2017/46739, 2017, A1, . Location in patent: Page/Page column 49
[2] European Journal of Medicinal Chemistry, 2017, vol. 141, p. 506 - 518
[3] Journal of Organic Chemistry, 2006, vol. 71, # 10, p. 3959 - 3962
[4] Journal of Medicinal Chemistry, 2006, vol. 49, # 19, p. 5671 - 5686
[5] Journal of Medicinal Chemistry, 2008, vol. 51, # 11, p. 3065 - 3068
[6] Journal of Heterocyclic Chemistry, 1997, vol. 34, # 2, p. 385 - 387
[7] Patent: WO2008/20203, 2008, A1, . Location in patent: Page/Page column 72
[8] Patent: WO2018/102751, 2018, A1, . Location in patent: Paragraph 00208
  • 18
  • [ 593-85-1 ]
  • [ 93777-26-5 ]
  • [ 190273-89-3 ]
YieldReaction ConditionsOperation in experiment
73% at 150℃; for 5 h; Guanidine carbonate (2) (4.47 g, 36.9 mmol) was added to a solution of 5-bromo-2-fluorobenzaldehyde (1) (5.00 g, 24.6 mmol) in dimethylacetamide (50 ml). The reaction mixture was heated at 150°C for 5 h. The progress of the reaction was monitored by TLC using AcOEt–hexane, 1:1, as eluent. The reaction mixture was cooled and quenched with ice water, and stirred for 30 min. Then the obtained solid was filtered off, and water was removed by azeotropic distillation with PhMe to get 4.00 g (73percent) of compound 3. Mp 270–272°C. 1H NMR spectrum (300 MHz), δ, ppm (J, Hz): 7.04 (2H, s,NH2); 7.37 (1H, d, J = 9.0, H Ar); 7.78 (1H, dd, J = 9.0,J = 2.4, H Ar); 8.05 (1H, d, J = 2.4, H Ar); 9.09 (1H, s,H Ar). Mass spectrum, m/z: 225 [M+H]+.
Reference: [1] Chemistry of Heterocyclic Compounds, 2015, vol. 51, # 1, p. 60 - 66[2] Khim. Geterotsikl. Soedin., 2015, vol. 51, # 1, p. 60 - 66,7
[3] Journal of Medicinal Chemistry, 2013, vol. 56, # 5, p. 1996 - 2015
  • 19
  • [ 593-85-1 ]
  • [ 206564-00-3 ]
Reference: [1] Heterocycles, 1998, vol. 47, # 2, p. 689 - 702
  • 20
  • [ 157327-41-8 ]
  • [ 593-85-1 ]
  • [ 869198-95-8 ]
YieldReaction ConditionsOperation in experiment
55% With sodium acetate In methanol for 17 h; Reflux Preparation 12
6-t-Butoxycarbonyl-5,6,7,8-tetrahydropyrido[4,3-d]pyrimidin-2-ylamine
A solution of 1-t-Butoxycarbonyl-3-(dimethylamino)methylene-4-piperidone (7.64 g, 30.04 mmol) in methanol (190 mL) was treated with guanidine carbonate (21.65 g, 120.16 mmol), followed by sodium acetate trihydrate (32.70 g, 240.32 mmol).
The reaction mixture was heated at reflux for 17 hours and the solvent was removed in vacuo.
The residue was diluted with water and the mixture was swirled for a few minutes.
The undissolved white solid was collected and washed with water, followed by a small amount of cold ethyl acetate to give the title compound (4.10 g, 55percent).
Reference: [1] Patent: US2013/237538, 2013, A1, . Location in patent: Paragraph 0188
  • 21
  • [ 1009734-34-2 ]
  • [ 593-85-1 ]
  • [ 1009734-33-1 ]
Reference: [1] Journal of Medicinal Chemistry, 2008, vol. 51, # 3, p. 449 - 469
Same Skeleton Products
Historical Records